Reply to the Comments on “GLM7—A Novel Composite Glycolipid Index Derived from Routine Health Indicators for Enhanced Diagnosis and Prediction of Multimorbidity”
Source abstract
Abstract
ABSTRACT This paper is a formal response to the comments raised by Yiquan Wang et al. and Peikai Sun et al. on our published work entitled “GLM7–A Novel Composite Glycolipid Index Derived from Routine Health Indicators for Enhanced Diagnosis and Prediction of Multimorbidity”. We address all the comments in this response. In addition, we emphasize the intended application scenarios and potential limitations of GLM7 and discuss future research efforts to improve its methodological rigor and interpretability.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Chronic Disease Management Strategies · Machine Learning in Healthcare · Gut microbiota and health
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Endocrinology and Metabolism Centre For Leading Medicine and Advanced Technologies of IHM The First Affiliated Hospital of USTC Division of Life Sciences and Medicine University of Science and Technology of China Hefei China
References (15)
Show source-provided references
1. 10.1002/advs.20251055210.1002/advs.202510552 ↗
2. 10.1002/advs.7461010.1002/advs.74610 ↗
3. 10.1002/advs.7480810.1002/advs.74808 ↗
4. 10.1093/ije/dys20310.1093/ije/dys203 ↗
5. 10.1093/aje/kwz17010.1093/aje/kwz170 ↗
6. 10.1136/bmj.b239310.1136/bmj.b2393 ↗
7. 10.1056/NEJMoa240629510.1056/NEJMoa2406295 ↗
8. 10.1056/NEJMoa100963810.1056/NEJMoa1009638 ↗
9. 10.1186/s12874‐021‐01261‐610.1186/s12874‐021‐01261‐6 ↗
10. 10.1093/aje/kwv34610.1093/aje/kwv346 ↗
11. 10.1016/j.jclinepi.2009.03.01710.1016/j.jclinepi.2009.03.017 ↗
12. 10.18637/jss.v045.i0310.18637/jss.v045.i03 ↗
13. 10.1093/biomet/86.4.94810.1093/biomet/86.4.948 ↗
14. 10.1007/s10654‐016‐0149‐310.1007/s10654‐016‐0149‐3 ↗
15. 10.1161/01.cir.0000048892.83521.5810.1161/01.cir.0000048892.83521.58 ↗